Update in global trends and aetiology of hepatocellular carcinoma

P Rawla, T Sunkara, P Muralidharan… - Contemporary Oncology …, 2018 - termedia.pl
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible
for an increasing number of cancer-related deaths, especially in develo** economies of …

[HTML][HTML] miR-122–a key factor and therapeutic target in liver disease

S Bandiera, S Pfeffer, TF Baumert, MB Zeisel - Journal of hepatology, 2015 - Elsevier
Being the largest internal organ of the human body with the unique ability of self-
regeneration, the liver is involved in a wide variety of vital functions that require highly …

CD39 Expression Identifies Terminally Exhausted CD8+ T Cells

PK Gupta, J Godec, D Wolski, E Adland, K Yates… - PLoS …, 2015 - journals.plos.org
Exhausted T cells express multiple co-inhibitory molecules that impair their function and limit
immunity to chronic viral infection. Defining novel markers of exhaustion is important both for …

Predictive validity in drug discovery: what it is, why it matters and how to improve it

JW Scannell, J Bosley, JA Hickman… - Nature Reviews Drug …, 2022 - nature.com
Successful drug discovery is like finding oases of safety and efficacy in chemical and
biological deserts. Screens in disease models, and other decision tools used in drug …

The circadian clock and liver function in health and disease

A Mukherji, SM Bailey, B Staels, TF Baumert - Journal of hepatology, 2019 - Elsevier
Each day, all organisms are subjected to changes in light intensity because of the Earth's
rotation around its own axis. To anticipate this geo-physical variability, and to appropriately …

[PDF][PDF] Hepatitis C virus drug resistance–associated substitutions: State of the art summary

E Lontok, P Harrington, A Howe, T Kieffer… - …, 2015 - Wiley Online Library
Hepatitis C virus (HCV) drug development has resulted in treatment regimens composed of
interferon‐free, all‐oral combinations of direct‐acting antivirals. While the new regimens are …

Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

MB Zeisel, J Lucifora, WS Mason, C Sureau, J Beck… - Gut, 2015 - gut.bmj.com
HBV infection is a major cause of liver cirrhosis and hepatocellular carcinoma. Although
HBV infection can be efficiently prevented by vaccination, and treatments are available, to …

[HTML][HTML] Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma

Y Hoshida, BC Fuchs, N Bardeesy, TF Baumert… - Journal of …, 2014 - Elsevier
Hepatitis C virus (HCV) is one of the major aetiologic agents that causes hepatocellular
carcinoma (HCC) by generating an inflammatory, fibrogenic, and carcinogenic tissue …

Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition

S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal… - Cancer cell, 2016 - cell.com
Cirrhosis is a milieu that develops hepatocellular carcinoma (HCC), the second most lethal
cancer worldwide. HCC prediction and prevention in cirrhosis are key unmet medical needs …

Improving drug design: an update on recent applications of efficiency metrics, strategies for replacing problematic elements, and compounds in nontraditional drug …

NA Meanwell - Chemical Research in Toxicology, 2016 - ACS Publications
Drug discovery and development is a complex and lengthy enterprise that suffers from high
rates of candidate attrition at all stages of the process. The physical, biological, and …